Journal list Promote Sponsor
verified SJR 0,962 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Clinical Proteomics
United Kingdom · BioMed Central Ltd
workspace_premium Q1 — Molecular Biology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Clinical Proteomics

Clinical Proteomics is a journal indexed in SJR in Molecular Biology and Molecular Medicine with an H index of 45. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1890 €. The scope of the journal is focused on translational proteomics, molecular medicine. It has an SJR impact factor of 0,962 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,962.

ISSN: 1542-6416
Publisher: BioMed Central Ltd
Category: Molecular Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,962 Q1
H-index 45
Acceptance rate pie_chart
34%
Source Acceptance_Rate
Time to publication hourglass_top
17 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.890 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,962

H-index

45

Docs (year)

69

Docs 3y

133

Total refs

3775

Cites 3y

427

Citable 3y

128

Cites/Doc 2y

3.12

Ref/Doc

54.71

Immediate OA

1890 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antibody-based tissue profiling as a tool for clinical proteomics

View more

Will Cancer Proteomics Suffer from Premature Death?

View more

Comparative analysis of human sperm glycocalyx from different freezability ejaculates by lectin microarray and identification of ABA as sperm freezability biomarker

View more

Clinical proteomics of enervated neurons

View more

Clinical proteomic analysis of scrub typhus infection

View more

Cancer Site-Specific Isoforms of ENOX2 (tNOX), A Cancer-Specific Cell Surface Oxidase

View more

Cancer proteomics

View more

Cancer Biomarker Discovery via Targeted Profiling of Multiclass Tumor Tissue-Derived Proteomes

View more

Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured

View more

Bioinformatics for Comparative Proteomics

View more

Application of sector protein microarrays to clinical samples

View more

Application of quantitative proteomics to the integrated analysis of the ubiquitylated and global proteomes of xenograft tumor tissues

View more
SHOW MORE ARTICLES

Antiproliferative heparan sulfate inhibiting hyaluronan and transforming growth factor-beta expression in human lung fibroblast cells

View more

18O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma

View more

Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA)

View more

Altered proteome profiles in maternal plasma in pregnancies with fetal growth restriction

View more

Affinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage

View more

Advances in mass spectrometry-based clinical biomarker discovery

View more

Adiponectin Receptor-1 C-Terminal Fragment (CTF) in Plasma: Putative Biomarker for Diabetes

View more

Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry

View more

A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

View more

A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9

View more

A multiplex platform for the identification of ovarian cancer biomarkers

View more

A Multi-feature Reproducibility Assessment of Mass Spectral Data in Clinical Proteomic Studies

View more

FAQs